Taiwan's PITDC ties up with US CRO PharmaNet

6 July 2011

Taiwan’s Medical and Pharmaceutical Industry Technology and Development Center (PITDC), a non-profit organization established for the express purpose of serving the domestic medical industry, has signed a memorandum on mutual cooperation with US-based contract clinical organization group PharmaNet Development, based in New Jersey.

“The memorandum of understanding will enhance the collaborative progress we look forward to making with Taiwan biotechnological enterprises,” PharmaNet vice president Isabel Desmarais said at the 2011 BIO International Convention in Washington DC, where the signing took place. “We hope to build a long-term friendship with outstanding businesses in Taiwan,” she added.

...deals with Aihol Biomedical and Pei Li

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK